Welcome

Thank you for your interest in our study! We are evaluating the efficacy of Caplyta compared to a placebo for the treatment of borderline personality disorder in adults aged 18 to 65. This study is conducted under the supervision of Dr. Jon Grant at the University of Chicago.

Please note that participation requires proximity to Chicago, as there will be two in-person visits to the University of Chicago—one for the initial baseline visit and another at the end of the study. In addition, there are four follow-up visits conducted via Zoom every two weeks over an eight-week period.

Participants who complete the study will be compensated $40 per visit. The information you provide here will remain confidential and will only be used to determine your eligibility for the study.

If you have any questions, please call us at 773-702-5523.

Question Title

* 1. Have you been diagnosed with borderline personality disorder?

Question Title

* 2. Are you willing to participate in an 8 week clinical trial where you may receive Caplyta or a placebo?

Question Title

* 3. Do you understand English and can respond to questions, both verbally and written, in the language?